Home

Avoro Capital Advisors LLC

CIK 1633313 · last filed 2026-07-27

Avoro Capital Advisors LLC is a corporate insider who has filed 26 SEC Form 4 insider transactions across 6 companies since 2017. The most recent filing, for SCTX, was dated Jul 27, 2026. Across all open-market trades the lifetime net is +$238.7M, making them a net buyer over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

6

Total Filings

26

Lifetime Open-Market Net

$238.74M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SCTX Director — — — $0 1 2026-07-27
WHWK Director — $4.47 — $0 3 2026-06-15
Whitehawk Therapeutics, Inc. (AADI) Delisted Director 3,471,752 $2.05 $7.12M $0 4 2025-03-04
CymaBay Therapeutics, Inc. (CBAY) Delisted 10%+ Owner — $32.48 — $0 3 2023-09-14
IMMUNOMEDICS INC (IMMU) Delisted Director 26,267,234 — — $288.76M 13 2020-06-22
Mirati Therapeutics, Inc. (MRTX) Delisted 10%+ Owner 3,800,000 $58.70 $223.06M -$50.02M 2 2019-07-25

Recent Filings

26 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-27 SCTX Grant (A) — $0 EDGAR
2026-06-15 WHWK Grant (A) — $0 EDGAR
2026-05-14 WHWK Grant (A) — $0 EDGAR
2025-06-16 WHWK Grant (A) — $0 EDGAR
2025-03-04 Whitehawk Therapeutics, Inc. (AADI) Delisted Grant (A) — $0 EDGAR
2024-06-14 Whitehawk Therapeutics, Inc. (AADI) Delisted Grant (A) — $0 EDGAR
2023-09-14 CymaBay Therapeutics, Inc. (CBAY) Delisted Mixed — $0 EDGAR
2023-06-20 Whitehawk Therapeutics, Inc. (AADI) Delisted Grant (A) — $0 EDGAR
2023-01-30 CymaBay Therapeutics, Inc. (CBAY) Delisted Buy (P) — $0 EDGAR
2022-09-26 Whitehawk Therapeutics, Inc. (AADI) Delisted Grant (A) +3,780,000 $47.25M EDGAR
Showing 1–10 of 26
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.